Comparing presbyopia eye drops
Two once-daily prescription eye drops now treat age-related blurry near vision. VIZZ (aceclidine 1.44%) and YUVEZZI (carbachol 2.75% / brimonidine tartrate 0.1%) work by a similar pinhole mechanism — but they differ in formulation, dosing flexibility, and cost. Here is a straightforward, physician-written comparison.
| YUVEZZI | VIZZ | |
|---|---|---|
| Active ingredient | Carbachol 2.75% + brimonidine tartrate 0.1% (two agents) | Aceclidine 1.44% (single agent) |
| Manufacturer | Visus Therapeutics | LENZ Therapeutics |
| How it works | Carbachol constricts the pupil (pinhole effect); brimonidine helps prevent the pupil from re-dilating, extending the effect. | Aceclidine is a pupil-selective miotic designed to constrict the pupil with minimal effect on the focusing muscle. |
| Dosing | One drop in each eye once daily. | One drop in each eye; a second drop may be given 2 hours later if needed. |
| Onset | About 30 minutes. | About 30 minutes. |
| Duration | Up to 10 hours. | Up to 10 hours. |
| Clinical evidence | Phase 3 BRIO-I: ≥3-line near-vision improvement sustained over 8 hours without meaningful loss of distance vision. | Phase 3 CLARITY program: ≥3-line near-vision improvement within 3 hours, lasting up to 10 hours, without meaningful loss of distance vision. |
| Common side effects | Eye pain or irritation on instillation, blurred vision, headache. | Instillation-site irritation, dim vision, headache. |
| Approximate cash price | $79 for 30 days; $198 for 90 days (~$66/month) exclusively through PhilRx. | Around $79 for a 25–30 day supply through the manufacturer's pharmacy partner. |
| Insurance | Cash-pay; typically FSA/HSA eligible. | Cash-pay; typically FSA/HSA eligible. |
Prices and clinical results are drawn from each manufacturer's published information and FDA-approved Prescribing Information, and may change. This page is educational and is not medical advice.
There is no head-to-head trial comparing the two drops, so no honest comparison can declare a winner. In practice the choice often comes down to individual response, tolerability, and cost:
YUVEZZI is a true once-daily drop with the lowest per-month cost at the 90-day supply (~$66/month through PhilRx), and its brimonidine component is designed to keep the pupil small for the full day.
VIZZ offers optional twice-in-a-day dosing and, as a pupil-selective agent, is designed to minimize effects on the eye's focusing muscle, which some clinicians believe may reduce brow ache and retinal traction concerns.
A physician who knows your eye history — especially any glaucoma, retinal disease, uveitis, or recent eye surgery — is the right person to weigh these trade-offs with you.